Companion Animal Diagnostics Market: Growth, Size, Share, and Trends

Report Code MD 7053
Published in Dec, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Hematology), Application (Clinical Pathology, Virology), Animal (Dogs, Cats, Horses), End User (Diagnostic Laboratories) - Global Forecast to 2029

Overview

The global companion animal diagnostics market, valued at US$2.75 billion in 2023, is forecasted to grow at a robust CAGR of 8.8%, reaching US$2.99 billion in 2024 and an impressive US$4.55 billion by 2029. Several factors, including technological advancements in companion animal diagnostics, rising pet ownership, and increase in veterinary expenditure, drive market growth. The companion animal diagnostics market has been segmented by product, technology, animal type, application, end user and region. The companion animal diagnostics market is segmented into consumables and instruments based on product. The market is also segmented based on technology into clinical biochemistry, immunodiagnostics, hematology, urinalysis, molecular diagnostics and other companion animal diagnostics technologies. Based on animal type, the companion animal diagnostics market is segmented into dogs, cats, horses and other companion animals. Based on application, the companion animal diagnostics market is segmented into clinical pathology, bacteriology, virology and parasitology. Based on end users, the companion animal diagnostics market is segmented into diagnostics laboratories, veterinary hospitals and clinics, research institutes and universities, and home-care settings. Government regulations, such as rigorous safety standards by the FDA and favorable reimbursement policies, also support market growth. These factors facilitate an increased adoption of companion animal diagnostics in veterinary healthcare systems.

Companion Animal Diagnostics Market– Global Forecast and Key Opportunities to 2029

Attractive Opportunities in the Companion Animal Diagnostics Market

Asia Pacific

The growing demand for rapid tests and portable instruments for point-of-care (POC) services is offering growth opportunities for players in the companion animal diagnostics market.

Growth in companion animal diagnostics market is mainly driven by the increasing companion animal population.

Rising demand for pet insurance and growing animal health expenditure are key driving factors of the companion animal diagnostics market.

The Asia Pacific companion animal diagnostics market is projected to reach USD 936.7 million by 2029 during the forecast period.

The Asia Pacific market is projected to register a CAGR of 10.5% during the forecast period. China and India are emerging as major growth hotspots within the regional market.

Global Companion Animal Diagnostics Market Dynamics

DRIVER: Expansion in companion animal population

A surge in the overall companion animal population and adoption rate has been witnessed on a global scale. According to several studies, keeping a companion animal is associated with positive health benefits, such as reduced cardiac arrhythmias, normalization of blood pressure, decreased anxiety, greater psychological stability, and improved well-being. The increasing pet population is expected to drive the demand for pet care products and services, which, in turn, will support the growth of dependent industries such as companion animal diagnostics.

North America:

  • The number of households that owned a companion pet has increased from 84.9 million (an estimated 67% of US households) in 2019−2020 to 87.0 million (an estimated 70% of US households) in 2022−2023. (Source: American Pet Products Association, US)
  • The number of households-owned dogs increased from 63.4 million in 2019−2020 to 65.0 million in 2023−2024. (Source: American Pet Products Association, US)

Europe:

  • The canine population in Europe increased from 104.34 million in 2022 to 106.36 million in 2023. (Source: European Pet Food Industry Federation, FEDIAF)

Other Regions and Emerging Countries:

  • Australia has around 62% of companion animal ownership, one of the highest rates in the world. There were an estimated 29 million pets in nearly 5 million households (of 7.9 million households in the country) in 2023. (Australian Veterinary Association (AVA))
  • According to the India International Pet Trade Fair, ~600,000 pets are adopted every year in India. The number of pets in the country increased from 30 million in 2020 to 38.5 million in 2023.

The growth in companion animal ownership and the willingness to spend on the health and welfare of companion animals will support the growth of this market.

RESTRAINT: Rising pet care costs

In the last ten years, pet care costs have increased significantly. According to the American Pet Products Association (APPA) 2020 report, veterinary care is the second-highest source of spending in the pet care community. The US, for example, will spend a total of USD150.6 billion on their pets by the end of 2024; according to projections, U.S. pet spending will total almost USD 200 billion in 2030. PetMD also reported that low-to-medium pet care costs had reached USD 250 to USD 4,500 in veterinary practices, with a high-end procedure priced anywhere between USD 5,000 and USD 20,000.

According to the APPA National Pet Owners Survey 2024, the average American pet owner spent USD 1,960 on their pet(s) in 2023. The average pet dog costs USD 143 per month in 2024; cat ownership costs USD 90.50 per month, per cat. 62.4% of American households own pets; among pet owners, 66.8% own dogs. In Germany, the annual veterinary cost is ~USD 162.9 (EUR 140) per dog and USD 75.61 (EUR 65) per cat. In Japan, pet owners spend around USD 2,000–3,000 (JPY 200,000–300,000) annually on pet health. This is mainly due to the availability of advanced monitoring, diagnostic, and therapeutic procedures in veterinary practices, which, though effective, come with high price tags. Advanced products and procedures play a significant role in treatments; however, the cost of materials and equipment used in these procedures is very high. For instance, diagnostic procedures for identifying sensitivity to antimicrobials, or the presence of infection using PCR or any other advanced technologies, are costlier than the actual treatment. Hence, pet owners and veterinarians are reluctant to invest so much for diagnostic purposes.

Although the pet insurance market is expanding, the number of animals covered for treatments is still very low. As a result, animal owners generally bear most of the cost of treatments. In addition, according to the Society for Practicing Veterinary Surgeons, along with the increasing pet insurance, the cost of veterinary treatment is rising by about 12% a year. The number of consultations with veterinary specialists for pet care is another factor responsible for the increasing pet healthcare costs. Furthermore, the lower-income in this profession compared to other advanced-degree professions such as dentistry and law puts pressure on veterinary professionals to increase their fees. High pet care costs directly impact the number of visits by pet owners to veterinary facilities, thereby restraining the growth of this market

 

OPPORTUNITY: Utilization of AI and ML for enhanced disease diagnosis

The use of advanced technologies, such as Artificial Intelligence (AI) and Machine Learning (ML), is only just emerging in the field of veterinary health. The utilization of these technologies aid and improve the accuracy of disease diagnosis in companion animals. Sometimes, these technologies are also combined with imaging or medical record data to analyze and interpret diagnosis patterns in animals ahead of time. For instance, Aptech Diagnostics (developed by Mars Petcare scientists) introduced its RenalTech tool to analyze and predict chronic kidney disease up to two years before the clinical diagnosis procedure. Chronic Kidney Disease (CKD) affects one-third of the cat population and is the leading cause of death in cats aged over five years. Similarly, VetAI launched its Joii App in partnership with pet insurer Animal Friends. This app uses AI and helps in the diagnosis of dermatological and inflammatory conditions while analyzing an uploaded photo of the injured animal.

However, the use of these technologies in routine clinical diagnosis is still considered to be in the nascent stage. According to studies published by the University of California and State Colorado University in 2019, utilizing machine learning on the routine CBC and serum chemistry panels aid in the diagnosis of Canine Hypoadrenocorticism (CHA) in dogs. CHA is a life-threatening condition affecting approximately 0.003% of the dog population. While other tests, such as the ACTH stimulation test, have several shortcomings (related to accuracy), the utilization of normal blood work and serum panels alongside their combination with ML enhances the accuracy of disease diagnosis. Hence, the utilization of these technologies makes for promising opportunities in the companion animal diagnostics market.

CHALLENGES: Shortage of veterinary practitioners in emerging markets

The global animal healthcare sector is significantly impacted by a shortage of skilled veterinarians and pathologists, a challenge that is especially pronounced in emerging markets such as those in Asia Pacific and Latin America. For instance, in India, the Veterinary Council of India (VCI) reported 81,938 veterinary professionals in 2023, but the country requires a minimum of 110,000-120,000 professionals to meet the standard of one veterinarian for every 5,000 animals. This shortage is also evident in countries like Brazil and China, where the demand for veterinary services far exceeds the supply of qualified professionals. This gap in supply is a key barrier to the growth of the animal healthcare industry, particularly the companion animal diagnostics market.

The limited availability of trained veterinarians restricts the adoption of advanced diagnostic solutions, which are crucial for timely and accurate diagnosis of companion animals. Furthermore, the high cost of these diagnostic tests presents an additional hurdle, particularly in developing countries where economic constraints make it difficult for many practices to afford such technologies. As a result, the lack of skilled professionals, combined with the financial barrier to adopting advanced diagnostic tools, hampers the growth potential of the animal healthcare market.

Global Companion Animal Diagnostics Market Ecosystem Analysis

This ecosystem market map represents the components of the companion animal diagnostics market, as well as defines them by demonstrating the bodies related to these elements. These include manufacturers, distributors, research & product developers, and customers.

Manufacturers include those for the whole research, design, product development, optimization, and launch of the product. Distributors include eCommerce sites linked to the organization for the marketing of animal health products and third parties. Research and product developers comprise in-house research of organizations as well as contract research organizations and contract development manufacturers, depending on which such activities or functions can be outsourced and hired. End users are where veterinary diagnostic test products have a major application. Some of the end users include Washington Animal Disease Diagnostic Laboratory, Veterinary Laboratory - University of Minnesota, Kansas State Veterinary, and Wisconsin Veterinary Laboratory.

Companion Animal Diagnostics Market
 

Consumables accounted for the largest market share in 2023.

In 2023, consumables segment accounted for the largest share of the companion animal diagnostics market due to their increasing demand for diagnostic tools and technology. This growth rate is mainly due to the emerging point-of-care solutions for quick and easy results that can be used by veterinary clinics and pet owners. The large consumable component of this kind of tool, which relies on the on-site testing followed by immediate diagnosis for pet owners or veterinary clinics, might include lateral flow assays, test kits, reagents, and imaging supplies. Lateral flow assay is a major kind of point-of-care diagnostics because of its simplicity, low cost, and speed in quick detection of different diseases and conditions for pets. Demand for consumables is further boosted by the growing emphasis on preventive care and the need for more and more tests to monitor chronic conditions, such as diabetes, kidney diseases, and cancer in pets. Besides, point-of-care instruments will also ease the burden on clinical veterinarians because tests can be done during regular visits and improved health outcomes will result due to early disease detection. The market is expected to grow substantially due to an increase in such adoption. While the technologies for diagnostics evolve further, consumables will always remain one of the key growth drivers in the companion animal diagnostics market.

Dogs held the largest share of the companion animal diagnostics market in 2023.

In 2023, dogs held largest share of the companion animal diagnostics market. Technological measures such as clinical biochemistry, immunodiagnostics, hematology, urinalysis, molecular diagnostics and other companion animal diagnostics technologies have been developed for diagnosing health in canines with the acceptance of the specific needs of their health. By studying certain prevalent diseases in dogs; for example, heart disease, cancer, diabetes, and infectious conditions, diagnostic approaches have been advanced to allow early detection for better treatment approaches. Increased usage of dog diagnostic services ranging from routine health screening to expensive tests for breed-specific diseases has increased market opportunities for this application. Increasingly, people adopt dogs as family members and look at giving them almost the same priority for health care; thus, they also are now driven to see what other health aspects can be improved through veterinary diagnostics. Hence, the increased understanding of canine health along with the growing need for diagnostic solutions specific to the different niches has fairly contributed to making the dogs segment the largest in the companion animal diagnostics market.

Asia Pacific to exhibit the highest growth rate during the forecast period.

In the Asia Pacific region, the market for companion animal diagnostics is likely to grow at the highest CAGR during the forecast period; it has continued to grow mostly through rapid urbanization and increasing pet ownership indices across the region. With more individuals migrating to urban areas, veterinary clinics and diagnostic services have become more easily accessed, thereby making healthcare seeking by pet owners more comfortable. Pet health is being emphasized with this urban migration; pet owners are becoming increasingly aware of the importance of proactive health management and diagnostics opportunities such as regular check-ups and preventive care. Afflicted pet owners can now access a modern diagnostic to explore various health problems-from chronic illnesses to infections. An increase in adoption has also been observed in diagnostic tests as more people get informed about when and how to detect diseases early. It still means that pet owners spend more, especially in markets in the developing world, such as China and India, where they are spending more on superior veterinary services, including advanced diagnostics.

The companion animal diagnostics market further continues to benefit from rising numbers in the pet population, especially in urban environments, as it will create more demand for accurate and easy pet health diagnostics. The fact that urbanization, increased awareness in pet healthcare, and improving access to companion animal diagnostics are combined makes the Asia Pacific an excellent driver for companion animal diagnostics growth.

HIGHEST CAGR MARKET IN 2024-2029
CHINA FASTEST GROWING MARKET IN THE REGION
Companion Animal Diagnostics Market

Recent Developments of Companion Animal Diagnostics Market

  • Product Launch: In June 2024, IDEXX (US) launched Catalyst Pancreatic Lipase Test (Chemistry Analyzer)— The Catalyst Pancreatic Lipase test is a single-slide solution for canine & feline patients that helps identify pancreatitis.
  • Product Launch: In May 2024, Zoetis Services LLC (US) launched the Vetscan OptiCell (Analyzer)— The Vetscan OptiCell is a cartridge-based AI-powered hematology analyzer that provides advanced Complete Blood Count (CBC) analysis.
  • Acquisition: In July 2024, Mars, Incorporated (US) acquired Cerba HealthCare’s ownership stake in Cerba Vet and ANTAGENE. Cerba Vet and ANTAGENE now complement the diagnostics portfolio in Mars Petcare’s Science & Diagnostics division.
  • Agreement: In March 2023, FUJIFILM Corporation (Japan) and Boule (Sweden) expanded its strategic agreement in Europe for veterinary solutions. FUJIFILM started to promote Boule product in three European countries in mid-2022. After successful results and excellent customer feedback FUJIFILM will now sell Boule’s veterinary hematology offering in five additional European countries.

Key Market Players

KEY PLAYERS IN THE COMPANION ANIMAL DIAGNOSTICS MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Companion Animal Diagnostics Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD Million)
Segments covered By Product, Technology, Animal Type, Application, End User and Region
Geographies covered North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, GCC Countries

 

Key Questions Addressed by the Report

Which are the top industry players in the companion animal diagnostics market?
The major players in this market are IDEXX (US), Zoetis Services LLC (US), Mars, Incorporated (US), FUJIFILM Corporation (Japan), bioMérieux (France).
Which product segments have been included in the companion animal diagnostics market report?
The report contains the following product segments:
  • Consumable
  • Instruments
Which region is dominating in the companion animal diagnostics market?
In 2023, North America accounted for the largest share of the companion animal diagnostics market. North America, particularly the U.S. and Canada, has a high rate of pet ownership, leading to greater demand for companion animal diagnostics, thus dominating the market.
What are emerging trends in the companion animal diagnostics market?
Expansion in companion animal, increasing demand for pet insurance and growing animal health expenditure and growing number of veterinary practitioners are the emerging trends in the companion animal diagnostics market.
What is the total CAGR expected to be recorded for the companion animal diagnostics market during 2024-2029?
It is expected to record a CAGR of 8.8% from 2024 to 2029.

 

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Companion Animal Diagnostics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table Of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
35
RESEARCH METHODOLOGY
41
EXECUTIVE SUMMARY
54
PREMIUM INSIGHTS
59
MARKET OVERVIEW
63
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Expansion in companion animal population
    - Increasing demand for pet insurance and growth in animal healthcare expenditure
    - Growing number of veterinary practitioners
    RESTRAINTS
    - Rising pet care costs
    OPPORTUNITIES
    - Growing demand for rapid tests and portable instruments for POC diagnostics
    - Utilization of AI and ML for enhanced disease diagnosis
    CHALLENGES
    - Shortage of veterinary practitioners in emerging markets
  • 5.3 INDUSTRY TRENDS
    ADOPTION OF MULTIPLE TESTING PANELS
    OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES
  • 5.4 DISEASE TRENDS
    ZOONOTIC DISEASES
    OBESITY & DIABETES
  • 5.5 TECHNOLOGICAL ANALYSIS
    KEY TECHNOLOGIES
    - Portable instruments
    COMPLEMENTARY TECHNOLOGIES
    - Wearable health monitoring devices
    ADJACENT TECHNOLOGIES
    - Rapid vet diagnostic kits
  • 5.6 TRADE ANALYSIS
    TRADE ANALYSIS OF MEDICAL DEVICE PRODUCTS (HS CODE 9018)
    EXPORT DATA FOR COMPANION ANIMAL DIAGNOSTICS CONSUMABLES & INSTRUMENTS (HS CODE 9018)
    IMPORT DATA FOR COMPANION ANIMAL DIAGNOSTICS CONSUMABLES & INSTRUMENTS (HS CODE 9018)
  • 5.7 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF COMPANION ANIMAL DIAGNOSTICS, BY KEY PLAYER (2023)
    AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTICS, BY REGION (2021–2023)
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.9 VALUE CHAIN ANALYSIS
  • 5.10 ECOSYSTEM ANALYSIS
  • 5.11 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.12 SUPPLY CHAIN ANALYSIS
  • 5.13 REGULATORY ANALYSIS
    REGULATORY LANDSCAPE
    - North America
    - Europe
    - Asia Pacific
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.14 PATENT ANALYSIS
    PATENT PUBLICATION TRENDS FOR COMPANION ANIMAL DIAGNOSTICS
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.15 KEY CONFERENCES & EVENTS, 2024−2025
  • 5.16 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.17 CASE STUDY ANALYSIS
    CASE STUDY 1: OPPORTUNITY ASSESSMENT FOR AUTOMATED IMMUNOASSAY ANALYZERS IN COMPANION ANIMAL IMMUNODIAGNOSTICS
    CASE STUDY 2: IDENTIFICATION OF INTESTINAL PARASITES IN PET DOGS
    CASE STUDY 3: INTRODUCTION OF PETLY PLANS BY IDEXX FOR HIGHER VOLUME OF PATIENT VISITS
  • 5.18 ADJACENT MARKET ANALYSIS
    VETERINARY DIAGNOSTICS MARKET
    VETERINARY REFERENCE LABORATORY MARKET
  • 5.19 UNMET NEEDS/END-USER EXPECTATIONS IN COMPANION ANIMAL DIAGNOSTICS MARKET
  • 5.20 IMPACT OF AI/GEN AI ON COMPANION ANIMAL DIAGNOSTICS MARKET
  • 5.21 INVESTMENT & FUNDING SCENARIO
COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT
99
  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    GROWING AWARENESS OF PREVENTIVE CARE TO DRIVE MARKET
  • 6.3 INSTRUMENTS
    ADOPTION OF RAPID TESTS FOR INFECTIOUS DISEASE DIAGNOSTICS TO PROPEL MARKET
COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION
103
  • 7.1 INTRODUCTION
  • 7.2 CLINICAL PATHOLOGY
    INCREASING VOLUME OF CLINICAL TESTS FOR DISEASE DIAGNOSIS TO DRIVE MARKET
  • 7.3 BACTERIOLOGY
    INCREASING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE MARKET
  • 7.4 VIROLOGY
    INCREASING INCIDENCE OF VIRAL OUTBREAKS TO SUPPORT MARKET GROWTH
  • 7.5 PARASITOLOGY
    RISING PREVALENCE OF KENNEL COUGH AND LYME DISEASE TO FUEL UPTAKE
  • 7.6 OTHER APPLICATIONS
COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE
110
  • 8.1 INTRODUCTION
  • 8.2 DOGS
    RISING PET DOG POPULATION TO DRIVE MARKET
  • 8.3 CATS
    GROWING FOCUS ON R&D FOR FELINE CARE TO FUEL UPTAKE
  • 8.4 HORSES
    INCREASING AWARENESS OF EQUINE HEALTH TO SUPPORT MARKET GROWTH
  • 8.5 OTHER COMPANION ANIMALS
COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER
119
  • 9.1 INTRODUCTION
  • 9.2 DIAGNOSTIC LABORATORIES
    INCREASING VOLUME OF SAMPLE TESTS TO DRIVE MARKET
  • 9.3 VETERINARY HOSPITALS & CLINICS
    RISING PET CARE EXPENDITURE TO FUEL MARKET
  • 9.4 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
    FAVORABLE INDUSTRY-ACADEMIA COLLABORATIONS TO SUPPORT MARKET GROWTH
  • 9.5 HOME CARE SETTINGS
    IMPROVED CARE AND COST EFFICIENCY TO PROPEL MARKET
COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY
127
  • 10.1 INTRODUCTION
  • 10.2 CLINICAL BIOCHEMISTRY
    CLINICAL CHEMISTRY ANALYSIS
    - Reagents, clips, and cartridges
    - Analyzers
    GLUCOSE MONITORING
    - Blood glucose strips
    - Glucose monitors
    - Urine glucose strips
    BLOOD GAS ELECTROLYTE ANALYSIS
    - Reagents, clips, and cartridges
    - Blood gas & electrolyte analyzers
  • 10.3 IMMUNODIAGNOSTICS
    LATERAL FLOW ASSAYS
    - Rapid tests
    - Strip readers
    ELISA TESTS
    - High sensitivity to fuel uptake
    ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
    - Increasing number of allergy cases in pets to support market growth
    IMMUNOASSAY ANALYZERS
    - Ability to handle large number of samples for immunoassay testing to boost demand
    OTHER IMMUNODIAGNOSTIC PRODUCTS
  • 10.4 HEMATOLOGY
    CARTRIDGES
    - Ability to measure hematocrit and hemoglobin levels in blood samples to drive market
    ANALYZERS
    - Complete blood analysis performance evaluation to boost demand
  • 10.5 URINALYSIS
    CLIPS & CARTRIDGES
    - Detection of UTIs in cats, dogs, and equine to boost demand
    URINE ANALYZERS
    - Rising technological advancements to support market growth
    URINE TEST STRIPS
    - Qualitative evaluation of leukocytes and protein to drive market
  • 10.6 MOLECULAR DIAGNOSTICS
    PCR TESTS
    - Increasing laboratory usage in proteomics & genomics to fuel market
    MICROARRAYS
    - Utilization of biochips in infectious disease diagnostics to support market
    OTHER MOLECULAR DIAGNOSTICS PRODUCTS
  • 10.7 OTHER TECHNOLOGIES
COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION
181
  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Rising pet healthcare expenditure to drive market
    CANADA
    - Growing awareness of pet health to propel market
  • 11.3 EUROPE
    ECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Growing feline & canine population to drive market
    UK
    - Stable increase in pet ownership and preventive measures against animal diseases to drive market
    FRANCE
    - Technological expertise and innovative advancements in diagnostics to fuel uptake
    ITALY
    - Increased pet adoption and enhanced availability of pet products to support market growth
    SPAIN
    - Rising animal health expenditure and growing number of veterinary facilities to drive market
    BENELUX
    - Increasing pet population in Benelux to fuel uptake
    REST OF EUROPE
  • 11.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - Rising cases of zoonotic diseases to drive market
    JAPAN
    - Increasing demand for imported pet breeds to drive market
    INDIA
    - Growth in animal healthcare industry to drive market
    AUSTRALIA
    - Growing focus on pet insurance to boost demand
    SOUTH KOREA
    - Growing focus on animal well-being to boost demand
    REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Growth in small animal population to support market
    MEXICO
    - Increasing adoption of advanced diagnostic technologies to fuel uptake
    REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    RELUCTANCE TO SPEND ON PET HEALTH TO RESTRAIN MARKET
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.7 GCC COUNTRIES
    INCREASING INCIDENCE OF INFECTIOUS DISEASES IN IMPORTED BREEDS TO SUPPORT MARKET GROWTH
    MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
COMPETITIVE LANDSCAPE
331
  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN COMPANION ANIMAL DIAGNOSTICS MARKET
  • 12.3 REVENUE ANALYSIS, 2019–2023
  • 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Technology footprint
    - Product footprint
    - Animal type footprint
    - Application footprint
    - End-user footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 12.7 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 R&D EXPENDITURE OF COMPANION ANIMAL DIAGNOSTICS COMPANIES
  • 12.10 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
354
  • 13.1 KEY PLAYERS
    IDEXX
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ZOETIS SERVICES LLC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MARS, INCORPORATED
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BIOMÉRIEUX
    - Business overview
    - Products offered
    - MnM view
    FUJIFILM CORPORATION
    - Business overview
    - Products offered
    - MnM view
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products offered
    NEOGEN CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    VIRBAC
    - Business overview
    - Products offered
    BOULE
    - Business overview
    - Products offered
    - Recent developments
    INDICAL BIOSCIENCE GMBH
    - Business overview
    - Products offered
    IDVET
    - Business overview
    - Products offered
    RANDOX LABORATORIES, LTD.
    - Business overview
    - Products offered
    SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
    - Business overview
    - Products offered
    BIONOTE USA INC.
    - Business overview
    - Products offered
    - Recent developments
    EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
    - Business overview
    - Products offered
  • 13.2 OTHER PLAYERS
    SKYLA CORPORATION
    EUROLYSER DIAGNOSTICA GMBH
    NOVA BIOMEDICAL
    FASSISI GMBH
    SWISS BIOTECH ASSOCIATION
    ALVEDIA
    BIOPANDA REAGENTS LTD.
    MEGACOR VETERINARY DIAGNOSTICS
    URIT MEDICAL ELECTRONIC CO., LTD.
    RING BIOTECHNOLOGY CO., LTD.
APPENDIX
409
  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 COMPANION ANIMAL DIAGNOSTICS MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES
  • TABLE 3 COMPANION ANIMAL DIAGNOSTICS MARKET: IMPACT ANALYSIS
  • TABLE 4 COMPANION ANIMAL DIAGNOSTIC MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 5 COMPANION ANIMAL DIAGNOSTICS MARKET: IMPACT ANALYSIS
  • TABLE 6 PET POPULATION, DOGS VS. CATS, 2020–2022 (MILLION)
  • TABLE 7 AVERAGE PREMIUMS PAID IN US, 2020 VS. 2023
  • TABLE 8 NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012–2023 (USD MILLION)
  • TABLE 9 MULTIPLE TESTING PANELS VS. SINGLE TESTING PANELS
  • TABLE 10 COMMON ZOONOTIC DISEASES TRANSMITTED BY INFECTED COMPANION ANIMALS
  • TABLE 11 POC PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS
  • TABLE 12 TRADE ANALYSIS OF MEDICAL DEVICE PRODUCTS, 2023 (USD MILLION)
  • TABLE 13 EXPORT DATA FOR COMPANION ANIMAL DIAGNOSTICS CONSUMABLES & INSTRUMENTS (HS CODE 9018), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 14 IMPORT DATA FOR COMPANION ANIMAL DIAGNOSTICS CONSUMABLES & INSTRUMENTS (HS CODE 9018), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 15 AVERAGE SELLING PRICE OF COMPANION ANIMAL DIAGNOSTICS, BY KEY PLAYER (2023)
  • TABLE 16 AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTICS, BY REGION, 2021–2023 (USD)
  • TABLE 17 COMPANION ANIMAL DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 COMPANION ANIMAL DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • TABLE 22 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS
  • TABLE 23 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
  • TABLE 24 COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 25 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 26 COMPANION ANIMAL DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 27 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 28 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CLINICAL PATHOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 29 COMPANION ANIMAL DIAGNOSTICS MARKET FOR BACTERIOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 30 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VIROLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 31 COMPANION ANIMAL DIAGNOSTICS MARKET FOR PARASITOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 32 COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 33 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 34 DOG POPULATION, BY COUNTRY, 2022–2024 (MILLION)
  • TABLE 35 COMPANION ANIMAL DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 36 CAT POPULATION, BY COUNTRY, 2022−2024 (USD MILLION)
  • TABLE 37 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 HORSE POPULATION, 2020–2022
  • TABLE 39 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 40 OTHER COMPANION ANIMALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 42 COMPANION ANIMAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 43 BASIC ANNUAL EXPENSES FOR CATS & DOGS IN US (2024) (USD)
  • TABLE 44 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 45 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 48 LIST OF KEY CLINICAL BIOCHEMISTRY PRODUCTS AVAILABLE
  • TABLE 49 CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 50 CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 51 LIST OF KEY CLINICAL CHEMISTRY ANALYSIS PRODUCTS AVAILABLE
  • TABLE 52 CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 53 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 54 CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 55 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2022–2029 (THOUSAND UNITS)
  • TABLE 57 LIST OF KEY GLUCOSE MONITORING PRODUCTS AVAILABLE
  • TABLE 58 GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 59 GLUCOSE MONITORING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 60 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 61 GLUCOSE MONITORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 GLUCOSE MONITORS MARKET, BY COUNTRY, 2022–2029 (THOUSAND UNITS)
  • TABLE 63 LIST OF KEY URINE GLUCOSE STRIPS AVAILABLE
  • TABLE 64 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 65 BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 66 BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 67 BLOOD GAS ELECTROLYTE REAGENTS, CLIPS, AND CARTRIDGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 68 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 69 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (THOUSAND UNITS)
  • TABLE 70 LIST OF KEY IMMUNODIAGNOSTIC PRODUCTS AVAILABLE
  • TABLE 71 IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 72 IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 73 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 74 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 75 LATERAL FLOW KITS: ADVANTAGES & DISADVANTAGES
  • TABLE 76 LIST OF KEY LATERAL TEST KITS AVAILABLE
  • TABLE 77 LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 78 LATERAL FLOW STRIP READERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 79 ELISA: ADVANTAGES & DISADVANTAGES
  • TABLE 80 LIST OF KEY ELISA TEST KITS AVAILABLE
  • TABLE 81 ELISA TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 82 ELISA TESTS MARKET, BY REGION, 2022–2029 (THOUSAND UNITS)
  • TABLE 83 LIST OF KEY ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC KITS AVAILABLE
  • TABLE 84 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 85 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2022–2029 (THOUSAND UNITS)
  • TABLE 86 LIST OF KEY IMMUNOASSAY ANALYZERS AVAILABLE
  • TABLE 87 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 88 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (THOUSAND UNITS)
  • TABLE 89 LIST OF KEY IMMUNOASSAY REAGENTS & CONSUMABLES AVAILABLE
  • TABLE 90 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 91 LIST OF KEY HEMATOLOGY PRODUCTS AVAILABLE
  • TABLE 92 HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 93 HEMATOLOGY MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 94 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 95 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 96 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (THOUSAND UNITS)
  • TABLE 97 LIST OF KEY URINALYSIS PRODUCTS AVAILABLE
  • TABLE 98 URINALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 99 URINALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 100 LIST OF KEY CLIPS & CARTRIDGES AVAILABLE
  • TABLE 101 URINALYSIS CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 102 URINE ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 103 URINE ANALYZERS MARKET, BY REGION, 2022–2029 (THOUSAND UNITS)
  • TABLE 104 URINE TEST STRIPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 105 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 106 MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 107 LIST OF KEY PCR TESTS AVAILABLE
  • TABLE 108 PCR TESTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 109 PCR TESTS MARKET, BY REGION, 2022–2029 (THOUSAND UNITS)
  • TABLE 110 LIST OF KEY MICROARRAY TESTS AVAILABLE
  • TABLE 111 MICROARRAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 112 MICROARRAYS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 113 OTHER MOLECULAR DIAGNOSTICS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 114 OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 115 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 116 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 117 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 118 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 119 NORTH AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 120 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 121 NORTH AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 122 NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 123 NORTH AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 124 NORTH AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 125 NORTH AMERICA: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 126 NORTH AMERICA: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 127 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 128 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 129 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 130 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 131 US: KEY MACROINDICATORS
  • TABLE 132 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 133 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 134 US: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 135 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 136 US: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 137 US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 138 US: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 139 US: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 140 US: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 141 US: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 142 US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 143 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 145 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 146 CANADA: KEY MACROINDICATORS
  • TABLE 147 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 148 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 149 CANADA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 150 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 151 CANADA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 152 CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 153 CANADA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 154 CANADA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 155 CANADA: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 156 CANADA: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 157 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 158 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 159 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 160 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 161 EUROPE: COMPANION ANIMAL POPULATION, 2022 (MILLION)
  • TABLE 162 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 163 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 164 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 165 EUROPE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 166 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 167 EUROPE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 168 EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 169 EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 170 EUROPE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 171 EUROPE: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 172 EUROPE: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 173 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 174 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 175 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 176 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 177 GERMANY: KEY MACROINDICATORS
  • TABLE 178 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 179 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 180 GERMANY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 181 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 182 GERMANY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 183 GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 184 GERMANY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 185 GERMANY: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 186 GERMANY: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 187 GERMANY: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 188 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 189 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 190 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 191 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 192 UK: HOUSEHOLDS WITH PETS (2022)
  • TABLE 193 UK: KEY MACROINDICATORS
  • TABLE 194 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 195 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 196 UK: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 197 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 198 UK: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 199 UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 200 UK: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 201 UK: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 202 UK: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 203 UK: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 204 UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 205 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 206 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 207 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 208 FRANCE: KEY MACROINDICATORS
  • TABLE 209 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 210 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 211 FRANCE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 212 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 213 FRANCE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 214 FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 215 FRANCE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 216 FRANCE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 217 FRANCE: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 218 FRANCE: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 219 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 220 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 221 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 222 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 223 ITALY: KEY MACROINDICATORS
  • TABLE 224 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 225 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 226 ITALY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 227 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 228 ITALY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 229 ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 230 ITALY: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 231 ITALY: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 232 ITALY: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 233 ITALY: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 234 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 235 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 236 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 237 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 238 SPAIN: KEY MACROINDICATORS
  • TABLE 239 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 240 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 241 SPAIN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 242 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 243 SPAIN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 244 SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 245 SPAIN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 246 SPAIN: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 247 SPAIN: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 248 SPAIN: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 249 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 250 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 251 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 252 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 253 BENELUX: KEY MACROINDICATORS
  • TABLE 254 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 255 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 256 BENELUX: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 257 BENELUX: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 258 BENELUX: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 259 BENELUX: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 260 BENELUX: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 261 BENELUX: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 262 BENELUX: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 263 BENELUX: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 264 BENELUX: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 265 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 266 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 267 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 268 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 269 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 270 REST OF EUROPE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 271 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 272 REST OF EUROPE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 273 REST OF EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 274 REST OF EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 275 REST OF EUROPE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 276 REST OF EUROPE: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 277 REST OF EUROPE: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 278 REST OF EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 279 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 280 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 281 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 282 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 283 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 284 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 285 ASIA PACIFIC: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 286 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 287 ASIA PACIFIC: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 288 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 289 ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 290 ASIA PACIFIC: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 291 ASIA PACIFIC: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 292 ASIA PACIFIC: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 293 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 294 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 295 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 296 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 297 CHINA: KEY MACROINDICATORS
  • TABLE 298 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 299 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 300 CHINA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 301 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 302 CHINA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 303 CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 304 CHINA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 305 CHINA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 306 CHINA: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 307 CHINA: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 308 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 309 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 310 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 311 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 312 JAPAN: KEY MACROINDICATORS
  • TABLE 313 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 314 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 315 JAPAN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 316 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 317 JAPAN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 318 JAPAN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 319 JAPAN: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 320 JAPAN: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 321 JAPAN: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 322 JAPAN: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 323 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 324 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 325 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 326 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 327 INDIA: KEY MACROINDICATORS
  • TABLE 328 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 329 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 330 INDIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 331 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 332 INDIA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 333 INDIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 334 INDIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 335 INDIA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 336 INDIA: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 337 INDIA: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 338 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 339 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 340 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 341 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 342 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 343 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 344 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 345 AUSTRALIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 346 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 347 AUSTRALIA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 348 AUSTRALIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 349 AUSTRALIA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 350 AUSTRALIA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 351 AUSTRALIA: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 352 AUSTRALIA: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 353 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 354 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 355 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 356 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 357 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 358 SOUTH KOREA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 359 SOUTH KOREA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 360 SOUTH KOREA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 361 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 362 SOUTH KOREA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 363 SOUTH KOREA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 364 SOUTH KOREA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 365 SOUTH KOREA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 366 SOUTH KOREA: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 367 SOUTH KOREA: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 368 SOUTH KOREA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 369 SOUTH KOREA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 370 SOUTH KOREA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 371 SOUTH KOREA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 372 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 373 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 374 REST OF ASIA PACIFIC: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 375 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 376 REST OF ASIA PACIFIC: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 377 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 378 REST OF ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 379 REST OF ASIA PACIFIC: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 380 REST OF ASIA PACIFIC: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 381 REST OF ASIA PACIFIC: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 382 REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 383 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 384 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 385 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 386 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 387 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 388 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 389 LATIN AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 390 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 391 LATIN AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 392 LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 393 LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 394 LATIN AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 395 LATIN AMERICA: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 396 LATIN AMERICA: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 397 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 398 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 399 LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 400 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 401 BRAZIL: KEY MACROINDICATORS
  • TABLE 402 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 403 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 404 BRAZIL: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 405 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 406 BRAZIL: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 407 BRAZIL: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 408 BRAZIL: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 409 BRAZIL: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 410 BRAZIL: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 411 BRAZIL: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 412 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 413 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 414 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 415 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 416 MEXICO: KEY MACROINDICATORS
  • TABLE 417 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 418 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 419 MEXICO: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 420 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 421 MEXICO: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 422 MEXICO: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 423 MEXICO: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 424 MEXICO: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 425 MEXICO: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 426 MEXICO: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 427 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 428 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 429 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 430 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 431 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 432 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 433 REST OF LATIN AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 434 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 435 REST OF LATIN AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 436 REST OF LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 437 REST OF LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 438 REST OF LATIN AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 439 REST OF LATIN AMERICA: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 440 REST OF LATIN AMERICA: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 441 REST OF LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 442 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 443 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 444 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 445 MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 446 MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 447 MIDDLE EAST & AFRICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 448 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 449 MIDDLE EAST & AFRICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 450 MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 451 MIDDLE EAST & AFRICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 452 MIDDLE EAST & AFRICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 453 MIDDLE EAST & AFRICA: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 454 MIDDLE EAST & AFRICA: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 455 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 456 MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 457 MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 458 MIDDLE EAST & AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 459 GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 460 GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 461 GCC COUNTRIES: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 462 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 463 GCC COUNTRIES: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 464 GCC COUNTRIES: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 465 GCC COUNTRIES: GLUCOSE MONITORING MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 466 GCC COUNTRIES: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 467 GCC COUNTRIES: HEMATOLOGY MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 468 GCC COUNTRIES: URINANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 469 GCC COUNTRIES: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 470 GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2022–2029 (USD MILLION)
  • TABLE 471 GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 472 GCC COUNTRIES: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 473 COMPANION ANIMAL DIAGNOSTICS MARKET: DEGREE OF COMPETITION
  • TABLE 474 COMPANION ANIMAL DIAGNOSTICS MARKET: REGION FOOTPRINT
  • TABLE 475 COMPANION ANIMAL DIAGNOSTICS MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 476 COMPANION ANIMAL DIAGNOSTICS MARKET: PRODUCT FOOTPRINT
  • TABLE 477 COMPANION ANIMAL DIAGNOSTICS MARKET: ANIMAL TYPE FOOTPRINT
  • TABLE 478 COMPANION ANIMAL DIAGNOSTICS MARKET: APPLICATION FOOTPRINT
  • TABLE 479 COMPANION ANIMAL DIAGNOSTICS MARKET: END-USER FOOTPRINT
  • TABLE 480 COMPANION ANIMAL DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUP/ SME PLAYERS
  • TABLE 481 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 482 COMPANION ANIMAL DIAGNOSTICS MARKET: PRODUCT LAUNCHES (JANUARY 2021−NOVEMBER 2024)
  • TABLE 483 COMPANION ANIMAL DIAGNOSTICS MARKET: DEALS (JANUARY 2021–NOVEMBER 2024)
  • TABLE 484 COMPANION ANIMAL DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2021– NOVEMBER 2024
  • TABLE 485 IDEXX: COMPANY OVERVIEW
  • TABLE 486 IDEXX: PRODUCTS OFFERED
  • TABLE 487 IDEXX: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 488 ZOETIS SERVICES LLC: COMPANY OVERVIEW
  • TABLE 489 ZOETIS SERVICES LLC: PRODUCTS OFFERED
  • TABLE 490 ZOETIS SERVICES LLC: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 491 ZOETIS SERVICES LLC.: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
  • TABLE 492 MARS, INCORPORATED: COMPANY OVERVIEW
  • TABLE 493 MARS, INCORPORATED: PRODUCTS OFFERED
  • TABLE 494 MARS, INCORPORATED: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 495 MARS, INCORPORATED: EXPANSIONS, JANUARY 2021–NOVEMBER 2024
  • TABLE 496 BIOMÉRIEUX: COMPANY OVERVIEW
  • TABLE 497 BIOMÉRIEUX: PRODUCTS OFFERED
  • TABLE 498 FUJIFILM CORPORATION: COMPANY OVERVIEW
  • TABLE 499 FUJIFILM CORPORATION: PRODUCTS OFFERED
  • TABLE 500 FUJIFILM CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 501 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 502 THERMO FISHER SCIENTIFIC INC: PRODUCTS OFFERED
  • TABLE 503 NEOGEN CORPORATION: COMPANY OVERVIEW
  • TABLE 504 NEOGEN CORPORATION: PRODUCTS OFFERED
  • TABLE 505 NEOGEN CORPORATION: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 506 VIRBAC: COMPANY OVERVIEW
  • TABLE 507 VIRBAC: PRODUCTS OFFERED
  • TABLE 508 BOULE: COMPANY OVERVIEW
  • TABLE 509 BOULE: PRODUCTS OFFERED
  • TABLE 510 BOULE: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 511 BOULE: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 512 INDICAL BIOSCIENCE GMBH: COMPANY OVERVIEW
  • TABLE 513 INDICAL BIOSCIENCE GMBH: PRODUCTS OFFERED
  • TABLE 514 IDVET: COMPANY OVERVIEW
  • TABLE 515 IDVET: PRODUCTS OFFERED
  • TABLE 516 RANDOX LABORATORIES, LTD.: COMPANY OVERVIEW
  • TABLE 517 RANDOX LABORATORIES, LTD.: PRODUCTS OFFERED
  • TABLE 518 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 519 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
  • TABLE 520 BIONOTE USA INC.: COMPANY OVERVIEW
  • TABLE 521 BIONOTE USA INC: PRODUCTS OFFERED
  • TABLE 522 BIONOTE USA INC.: PRODUCT LAUNCHES, JANUARY 2021–NOVEMBER 2024
  • TABLE 523 BIONOTE USA INC.: DEALS, JANUARY 2021–NOVEMBER 2024
  • TABLE 524 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG: COMPANY OVERVIEW
  • TABLE 525 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG: PRODUCTS OFFERED
LIST OF FIGURES
 
  • FIGURE 1 COMPANION ANIMAL DIAGNOSTICS MARKET: MARKETS COVERED & REGIONS CONSIDERED
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND SIDE PARTICIPANTS, BY END USER, DESIGNATION, AND REGION
  • FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
  • FIGURE 8 SUPPLY SIDE ANALYSIS OF LEADING COMPANIES (2023)
  • FIGURE 9 CAGR PROJECTIONS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF COMPANION ANIMAL DIAGNOSTICS MARKET (2024–2029)
  • FIGURE 10 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
  • FIGURE 11 TOP-DOWN APPROACH
  • FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 13 COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 GEOGRAPHIC SNAPSHOT: COMPANION ANIMAL DIAGNOSTICS MARKET
  • FIGURE 19 GROWING COMPANION ANIMAL POPULATION TO PROPEL MARKET
  • FIGURE 20 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 21 CLINICAL CHEMISTRY SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN CHINA IN 2023
  • FIGURE 22 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 23 COMPANION ANIMAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 US: PET EXPENDITURE, DOGS VS CATS, 2024 (USD)
  • FIGURE 25 AVERAGE SELLING PRICE TREND OF IMMUNODIAGNOSTICS, BY REGION (2021–2023)
  • FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • FIGURE 27 COMPANION ANIMAL DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 28 COMPANION ANIMAL DIAGNOSTICS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 COMPANION ANIMAL DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 30 COMPANION ANIMAL DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 31 PATENT PUBLICATION TRENDS (2014–APRIL 2024)
  • FIGURE 32 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR COMPANION ANIMAL DIAGNOSTICS DIAGNOSTIC PATENTS (JANUARY 2014–DECEMBER 2024)
  • FIGURE 33 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS
  • FIGURE 34 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
  • FIGURE 35 VETERINARY DIAGNOSTICS MARKET OVERVIEW
  • FIGURE 36 VETERINARY REFERENCE LABORATORY MARKET OVERVIEW
  • FIGURE 37 IMPACT OF AI/GEN AI ON COMPANION ANIMAL DIAGNOSTICS MARKET
  • FIGURE 38 NUMBER OF DEALS & FUNDS IN COMPANION ANIMAL DIAGNOSTICS MARKET, 2018–2022 (USD MILLION)
  • FIGURE 39 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022
  • FIGURE 40 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022 (USD MILLION)
  • FIGURE 41 CORNELL UNIVERSITY: SPONSORED RESEARCH & DIRECT COST EXPENSES BETWEEN FY 2019−FY 2023 (USD MILLION)
  • FIGURE 42 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 43 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 44 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PRODUCT COMPANIES
  • FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS IN COMPANION ANIMAL DIAGNOSTICS MARKET (2019–2023)
  • FIGURE 46 MARKET SHARE ANALYSIS OF KEY PLAYERS IN COMPANION ANIMAL DIAGNOSTICS MARKET (2023)
  • FIGURE 47 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 48 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPANY FOOTPRINT
  • FIGURE 49 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 50 EV/EBITDA OF KEY VENDORS
  • FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 52 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 53 R&D EXPENDITURE OF KEY PLAYERS (2022 VS. 2023)
  • FIGURE 54 IDEXX: COMPANY SNAPSHOT (2023)
  • FIGURE 55 ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2023)
  • FIGURE 56 BIOMÉRIEUX: COMPANY SNAPSHOT (2023)
  • FIGURE 57 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 58 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 59 NEOGEN CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 60 VIRBAC: COMPANY SNAPSHOT (2024)
  • FIGURE 61 BOULE: COMPANY SNAPSHOT (2023)

This research study involved the extensive use of both primary and secondary sources. It involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

Secondary Research

This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, white papers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the companion animal diagnostics market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply side and demand side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the companion animal diagnostics market. Primary sources from the demand side included veterinary hospitals, clinics, researchers, lab technicians, purchase managers etc, and stakeholders in corporate & government bodies.

A breakdown of the primary respondents for companion animal diagnostics market (supply side) market is provided below:

Companion Animal Diagnostics Market

Note 1: Companies are classified into tiers based on their total revenue. As of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

Note 2: C-level executives include CEOs, COOs, CTOs, and VPs.

Note 3: Other primaries include sales managers, marketing managers, and product managers.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size for companion animal diagnostics market was calculated using data from four different sources, as will be discussed below. Each technique concluded and a weighted average of the four ways was calculated based on the number of assumptions each approach made. The market size for companion animal diagnostics market was calculated using data from three distinct sources, as will be discussed below:

Companion Animal Diagnostics Market

Data Triangulation

The entire market was split up into five segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at the precise statistics for all segments.

Approach to derive the market size and estimate market growth.

Using secondary data from both paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of companion animal diagnostics. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

Market Definition

Companion animal diagnostics are tools that utilize plasma, serum, blood, urine, feces, and tissue samples for the diagnosis of animal diseases and disorders. Companion animal diagnostics includes various test kits, tools, and instruments such as clinical chemistry analyzers, hematology analyzers, glucose monitoring systems, urine analyzers, blood gas-electrolyte analyzers, and ELISA test kits.

Stakeholders

  • Companion animal diagnostic manufacturers
  • Companion animal diagnostic distributors & suppliers
  • Companion animal R&D companies
  • Veterinary reference laboratories
  • Veterinary hospitals & clinics
  • Veterinary universities & research institutes
  • Government associations 
  • Market research & consulting firms
  • Venture capitalists & investors
  • Distributors, channel partners, and third-party suppliers

Report Objectives

  • To define, describe, and forecast the companion animal diagnostics market based on product, technology, animal type, application, end user and region.
  • To provide detailed information about the major factors influencing the market growth (such as drivers, restraints, challenges, and opportunities)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall companion animal diagnostics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the companion animal diagnostics market in North America, Europe, the Asia Pacific, Latin America, Middle East & Africa and GCC Countries
  • To profile the key players and comprehensively analyze their market shares and core competencies in the companion animal diagnostics market
  • To track and analyze competitive developments such as partnerships, expansions, acquisitions, collaborations, product launches, agreements, and other developments in the companion animal diagnostics market
  • To benchmark players within the companion animal diagnostics market using the Company Evaluation Quadrant framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

Previous Versions of this Report

Companion Animal Diagnostics Market by Technology (Immunodiagnostic, Clinical Biochemistry, Molecular Diagnostics, Hematology), Application (Clinical Pathology, Bacteriology, Virology), Animal, End User (Diagnostics Labs, Clinics) - Global Forecast to 2027

Report Code MD 7053
Published in Apr, 2022, By MarketsandMarkets™

Companion Animal Diagnostics Market by Technology (Immunodiagnostic, Clinical Biochemistry, Hematology, Urine Analysis), Application (Clinical Pathology, Virology, Bacteriology, Parasitology), Animal (Dog, Cat, Horse), End-User - Global Forecast to 2025

Report Code MD 7053
Published in Mar, 2020, By MarketsandMarkets™

Companion Animal Diagnostics Market by Technology (Immunodiagnostic, Clinical Biochemistry, Hematology, Urine Analysis), Application (Clinical Pathology, Virology, Bacteriology, Parasitology), Animal (Dog, Cat, Horse), End-User - Global Forecast to 2025

Report Code MD 7053
Published in Apr, 2019, By MarketsandMarkets™

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Companion Animal Diagnostics Market

+1-888600-6441

Corporate Office Hours

+1-888600-6441

US/Can Toll Free

+44-800-368-9399

UK Office Hours

©2024 Marketsandmarkets Research Private Ltd. All Rights Reserved.

DMCA.com Protection Status